Invivyd (IVVD) Cash & Current Investments (2020 - 2025)

Invivyd (IVVD) reported Cash & Current Investments of $226.7 million for Q4 2025, up 226.88% on a YoY basis from $69.3 million in Q4 2024, and up 166.8% quarter-over-quarter from $85.0 million in Q3 2025.

Invivyd (IVVD) Cash & Current Investments (2020 - 2025) Analysis & Trends

Invivyd has reported Cash & Current Investments for 6 years, with the latest figure at $226.7 million in Q4 2025.

  • For the quarter ending Q4 2025, Cash & Current Investments rose 226.88% year-over-year to $226.7 million; the trailing twelve-month figure through Dec 2025 stood at $226.7 million (up 226.88% YoY), and the FY2025 full-year result was $226.7 million, up 226.88% from the prior year.
  • Cash & Current Investments for Q4 2025 stood at $226.7 million, up from $85.0 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $542.2 million in Q4 2021, with the low at $34.9 million in Q2 2025.
  • Historically, Cash & Current Investments has averaged $227.9 million across 5 years, with a median of $181.8 million in 2023.
  • Annual changes were most pronounced in 2021 — Cash & Current Investments jumped 371.55% — and 2022, when it plunged 83.02%.
  • Invivyd's Cash & Current Investments stood at $542.2 million in 2021, then sank by 83.02% to $92.1 million in 2022, then soared by 117.91% to $200.6 million in 2023, then slumped by 65.44% to $69.3 million in 2024, then surged by 226.88% to $226.7 million in 2025.
  • The last three Cash & Current Investments figures came in at $226.7 million (Q4 2025), $85.0 million (Q3 2025), and $34.9 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 32.30 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 2.13 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 286.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 18.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 2.77 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 7.20 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 7.25 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Invivyd 168.41 Mn -58.28 Mn - 226.69 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 226.69 Mn
Sep 30, 2025 84.97 Mn
Jun 30, 2025 34.91 Mn
Mar 31, 2025 48.08 Mn
Dec 31, 2024 69.35 Mn
Sep 30, 2024 106.87 Mn
Jun 30, 2024 147.88 Mn
Mar 31, 2024 189.39 Mn
Dec 31, 2023 200.64 Mn
Sep 30, 2023 181.82 Mn
Jun 30, 2023 121.95 Mn
Mar 31, 2023 126.47 Mn
Dec 31, 2022 92.08 Mn
Sep 30, 2022 278.15 Mn
Jun 30, 2022 474.89 Mn
Mar 31, 2022 532.22 Mn
Dec 31, 2021 542.22 Mn
Sep 30, 2021 478.27 Mn
Jun 30, 2021 392.51 Mn
Dec 31, 2020 114.99 Mn